Must every aspect of a research study be documented in compliance with Good Clinical Practice (GCP) guidelines to obtain useful data?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The correct answer is A. TRUE. According to Good Clinical Practice (GCP) guidelines, every aspect of a research study must be thoroughly documented to ensure data integrity and usefulness, as supported by the American Society of Clinical Oncology statement on minimum standards and exemplary attributes of clinical trial sites 1. This comprehensive documentation requirement is fundamental to GCP compliance and serves multiple critical purposes, including:

  • Creating an audit trail that allows for verification of study procedures
  • Protecting research participants
  • Ensuring scientific validity
  • Facilitating regulatory oversight Without complete documentation, data collected during research may be considered unreliable or unusable for regulatory submissions. The principle of "what is not documented is considered not done" is central to GCP, emphasizing that documentation is not merely administrative but essential to the scientific and ethical validity of research, as implied by the importance of meeting minimum criteria for quality clinical trials 1. Proper documentation includes everything from protocol development and ethics committee approvals to informed consent processes, adverse event reporting, and data collection methods.

From the Research

GCP Certification

  • The statement "every aspect of a research study must be documented in compliance with GCP guidelines in order to obtain useful data" is related to Good Clinical Practice (GCP) principles.
  • GCP guidelines emphasize the importance of accurate and complete documentation of all aspects of a research study to ensure the quality and integrity of the data collected.
  • According to GCP principles, documentation is essential for verifying the conduct of the study, the data collected, and the results obtained.
  • The provided studies do not directly address the question of GCP certification, but they demonstrate the importance of proper documentation and adherence to guidelines in research studies 2, 3, 4, 5, 6.
  • Based on the general principles of GCP, it can be inferred that proper documentation is crucial for obtaining useful data in research studies.

Answer to the Question

  • The correct answer is: A. TRUE
  • This answer is based on the general principles of GCP, which emphasize the importance of documentation and adherence to guidelines in research studies.
  • The provided studies do not directly address the question, but they support the importance of proper documentation and adherence to guidelines in research studies 2, 3, 4, 5, 6.

Related Questions

What methods ensure participant confidentiality in research, such as proper disposal of Protected Health Information (PHI) documentation, secure record storage, or assigning security codes to electronic records?
Do researchers and research institutions have the primary responsibility for reporting and investigating allegations of research misconduct, specifically regarding Good Clinical Practice (GCP)?
What is the required timeframe for reporting a Serious Adverse Event (SAE) to the local Institutional Review Board (IRB) after becoming aware of the event?
What action should be taken in case of a protocol violation in a clinical trial?
Is it important that findings from a clinical study be generalizable to people with similar characteristics as the study participants, for Good Clinical Practice (GCP) certification?
What are the clinical, pathological, and molecular characteristics for adding anti-Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) therapy in non-small cell lung cancer?
What are the clinical, pathological, and molecular characteristics for adding anti-Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) therapy in non-small cell lung cancer?
What is the creatinine level at which metformin (Metformin Hydrochloride) cannot be used due to Impaired Renal Function?
What clinical, pathological, and molecular characteristics are associated with the addition of anti-Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) therapy in non-small cell lung cancer?
What clinical, pathological, and molecular characteristics are associated with the addition of anti-Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) therapy in non-small cell lung cancer?
What is not an appropriate response to a protocol violation: reducing sample size, documenting and reporting to Institutional Review Board (IRB), or addressing participant safety concerns?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.